Fusion Antibodies Plc Financial Overview
Fusion Antibodies Plc's market cap is currently £20.03M. The company's EPS TTM is p; its P/E ratio is ―; Fusion Antibodies Plc is scheduled to report earnings on September 4, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
